Position in SVTR
Snapshot 2026-11-04- Startup SignalsRankedof 2,294↓32
- Life SciencesRankedof 241↓1
- Medtech DeviceRankedof 44–
About
FIZE Medical is an Israeli MedTech company transforming fluid management for critically ill patients; its FIZE kUO system, commercially available in Japan, Europe and the U.S., provides real-time digital urine-output monitoring, and it is developing the AI-driven predictive platform FIZE Optima.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 2
Founders / team· 1
Funding history
- 2026-09-17Series B未披露
Investors · Asahi Kasei Medical, Rapha Capital ManagementSource · prnewswire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- FIZE Medical
Digital urine output monitoring and smart fluid management for critical care (FIZE kUO)
Series B · 2026-09
—
United States
BusinessLatest roundTotal raisedDate- Epitel
Wireless wearable remote EEG monitoring system (REMI) + AI seizure event detection (REMI Vigilenz)
Series B · $39M · 2026-07
$39M - Aurenar
V-Link, a non-invasive…
Seed · $6M · 2026-07
$6M - Mira
Connected at-home hormone monitor, disposable test sticks, AI analysis app and online hormone health clinic for women trying to conceive…
$5M
$5M
China
BusinessLatest roundTotal raisedDate- Jiangsu Apon Medical Technology Co., Ltd.
R&D, manufacturing and sales of pain management devices (electronic analgesia pumps…
— - 永新医疗
Manufacturer of nuclear medicine imaging (SPECT/SPECT-CT, etc.) and nuclear radiation monitoring equipment
Series B · 2025-12
— - Xensur Medical
AR simulation training and AI surgical data analysis system for cataract surgery, for ophthalmology resident training
—
Europe
BusinessLatest roundTotal raisedDate- MyndBlue
Wearable and AI-based remote objective monitoring and early warning for depression and PTSD
— - Implicity
Data aggregation and AI risk alert platform for remote monitoring of cardiac implantable electronic devices (CIEDs)
Undisclosed · 2026-09
— - XRlabs
XRlabs SIM (CT/MRI to 3D digital twins for surgical rehearsal) and SurgicalOS (real-time AI video and instrument tracking) for hospitals and surgeons
Seed · 2026-10
—
Other / unspecified
BusinessLatest roundTotal raisedDate- Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M - Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive …
Pre-Seed · $3M · 2026-09
$3M - UltraSight
AI-guided cardiac ultrasound workflow platform (Echosystem) enabling non-specialist clinicians to perform diagnostic-grade echocardiograms at the beds…
Series B · $42M · 2026-09
$42M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
38 Life Sciences deals in the last 24 months · 21 at a nearby stage · 1 in Israel
Request intro →Insight Partners
14 Life Sciences deals in the last 24 months · 11 at a nearby stage · 1 in Israel
Request intro →OrbiMed Advisors
9 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in Israel
Request intro →Connecticut Innovations
6 Life Sciences deals in the last 24 months · 2 at a nearby stage · 2 in Israel
Request intro →Entrée Capital
5 Life Sciences deals in the last 24 months · 3 at a nearby stage · 1 in Israel
Request intro →NVentures
5 Life Sciences deals in the last 24 months · 2 at a nearby stage · 1 in Israel
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.